These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28487297)

  • 1. MECHANISMS IN ENDOCRINOLOGY: Towards the clinical translation of stem cell therapy for type 1 diabetes.
    Espes D; Lau J; Carlsson PO
    Eur J Endocrinol; 2017 Oct; 177(4):R159-R168. PubMed ID: 28487297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of human pluripotent stem cells into β-cells: Potential and challenges.
    Quiskamp N; Bruin JE; Kieffer TJ
    Best Pract Res Clin Endocrinol Metab; 2015 Dec; 29(6):833-47. PubMed ID: 26696513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell-based treatments for Type 1 diabetes mellitus: bone marrow, embryonic, hepatic, pancreatic and induced pluripotent stem cells.
    Godfrey KJ; Mathew B; Bulman JC; Shah O; Clement S; Gallicano GI
    Diabet Med; 2012 Jan; 29(1):14-23. PubMed ID: 21883442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards a Functional Cure for Diabetes Using Stem Cell-Derived Beta Cells: Are We There Yet?
    Bourgeois S; Sawatani T; Van Mulders A; De Leu N; Heremans Y; Heimberg H; Cnop M; Staels W
    Cells; 2021 Jan; 10(1):. PubMed ID: 33477961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regenerative medicine for diabetes: differentiation of human pluripotent stem cells into functional β-cells in vitro and their proposed journey to clinical translation.
    Bose B; Katikireddy KR; Shenoy PS
    Vitam Horm; 2014; 95():223-48. PubMed ID: 24559920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pluripotent stem cell replacement approaches to treat type 1 diabetes.
    Pellegrini S; Piemonti L; Sordi V
    Curr Opin Pharmacol; 2018 Dec; 43():20-26. PubMed ID: 30071348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem Cell-Based Therapies: A New Ray of Hope for Diabetic Patients.
    Khan J; Alexander A; Agrawal M; Ajazuddin ; Dubey SK; Siddique S; Saraf S; Saraf S
    Curr Stem Cell Res Ther; 2019; 14(2):146-151. PubMed ID: 30280677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
    El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
    Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell therapies for Type 1 diabetes: current status and proposed road map to guide successful clinical trials.
    Senior PA; Pettus JH
    Diabet Med; 2019 Mar; 36(3):297-307. PubMed ID: 30362170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generating insulin-producing cells for diabetic therapy: existing strategies and new development.
    Shen J; Cheng Y; Han Q; Mu Y; Han W
    Ageing Res Rev; 2013 Mar; 12(2):469-78. PubMed ID: 23318683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell therapy emerging as the key player in treating type 1 diabetes mellitus.
    Vanikar AV; Trivedi HL; Thakkar UG
    Cytotherapy; 2016 Sep; 18(9):1077-86. PubMed ID: 27424148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient generation of functional pancreatic β-cells from human induced pluripotent stem cells.
    Yabe SG; Fukuda S; Takeda F; Nashiro K; Shimoda M; Okochi H
    J Diabetes; 2017 Feb; 9(2):168-179. PubMed ID: 27038181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of Induced Pluripotent Stem Cell Therapies for Treatment of Type 1 Diabetes.
    Duffy C; Prugue C; Glew R; Smith T; Howell C; Choi G; Cook AD
    Tissue Eng Part B Rev; 2018 Dec; 24(6):482-492. PubMed ID: 29947303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of fulminant type 1 diabetes: Genes, viruses and the immune mechanism, and usefulness of patient-derived induced pluripotent stem cells for future research.
    Hosokawa Y; Hanafusa T; Imagawa A
    J Diabetes Investig; 2019 Sep; 10(5):1158-1164. PubMed ID: 31161717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic Endoderm-Derived From Diabetic Patient-Specific Induced Pluripotent Stem Cell Generates Glucose-Responsive Insulin-Secreting Cells.
    Rajaei B; Shamsara M; Amirabad LM; Massumi M; Sanati MH
    J Cell Physiol; 2017 Oct; 232(10):2616-2625. PubMed ID: 27306424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell therapy for type 1 diabetes.
    Muir KR; Lima MJ; Docherty HM; Docherty K
    QJM; 2014 Apr; 107(4):253-9. PubMed ID: 24481872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem Cell Therapy for Diabetes Mellitus: Recent Progress and Hurdles.
    Saleem M; Sabir S; Akhtar MF; Zahid S; Niazi SG; Naeem M; Saleem U; Saleem A
    Crit Rev Eukaryot Gene Expr; 2019; 29(5):471-482. PubMed ID: 32422003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cells and the endocrine pancreas.
    Wu Y; Persaud SJ; Jones PM
    Br Med Bull; 2011; 100():123-35. PubMed ID: 21642368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. iPSC technology-based regenerative therapy for diabetes.
    Kondo Y; Toyoda T; Inagaki N; Osafune K
    J Diabetes Investig; 2018 Mar; 9(2):234-243. PubMed ID: 28609558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cells to restore insulin production and cure diabetes.
    Sordi V; Pellegrini S; Krampera M; Marchetti P; Pessina A; Ciardelli G; Fadini G; Pintus C; Pantè G; Piemonti L
    Nutr Metab Cardiovasc Dis; 2017 Jul; 27(7):583-600. PubMed ID: 28545927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.